EDELMAN JOSEPH 4
4 · OPTIMER PHARMACEUTICALS INC · Filed Jul 25, 2008
Insider Transaction Report
Form 4
EDELMAN JOSEPH
10% Owner
Transactions
- Sale
Common Stock
2008-07-02$7.40/sh−192,000$1,420,800→ 2,540,613 total(indirect: see footnote) - Sale
Common Stock
2008-07-02$7.40/sh−8,000$59,200→ 113,442 total(indirect: see footnote)
Footnotes (3)
- [F1]This Form 4 is being filed by Perceptive Life Science Master Fund Ltd. (the "Master Fund"), Perceptive Advisors LLC ("Advisors") and Joseph Edelman.
- [F2]These transactions were effected through the Master Fund, over which Mr. Edelman has sole voting and dispositive power. Mr. Edeman is the managing member of Advisors, which in turn serves as the investment manager of Master fund. In accordance with Instruction 5(b) (iv) of Form 4, the entire amount of the Issuer's securities held by master Fund is reported herein. Each of Mr. Edelman and Advisors disclaims, for purposes of Section 16 of the Securities Exchange Act of 1934, beneficial ownership of such securities, except to the extent of his/its indirect pecuniary interest therein, and this report shall not be deemed an admission that Mr. Edelamn or Advisors is the beneficial owner of such securities for purposes of Section 16 or for any other purposes.
- [F3]These transactions were effected through an account at First New York Trading, LLC, over which Mr. Edelman has sole voting share dispositive power. Mr. Edelman disclaims, for purposed of Section 16 of the Securities Exchange Act of 1934, beneficial ownership of such securities, except to the extent of his indirect pecuniary interest therein, and this report shall not be deemed an admission that Mr. Edelman is the beneficial owner of such securities for purposes of Section 16 or for any other purposes.